Issues
-
Cover image
Cover Image
Confocal section of a Drosophila scrib tumor showing adhered hemocytes, labeled by He-Gal4-driven GFP expression (cyan). All nuclei stained with DAPI (red). See research article by Pastor-Pareja et al. on page 144. - PDF Icon PDF LinkTable of contents
IN THIS ISSUE
RESEARCH HIGHLIGHT
EDITORIAL
COMMUNITY NEWS
A high-tech infusion for science
Alex Griekspoor’s PhD in cell biology led to an interesting and unexpected twist that resulted in a unique career in computer programming. Now he creates new computer technology using his blend of research knowledge and computer prowess. After bringing the science community programs like Papers and 4Peaks, Dr Griekspoor started his own software company, mekentosj.com and the future looks bright.
A MODEL FOR LIFE
The future of cancer therapy: an interview with Gerard Evan
Gerard Evan is a founding editor of DMM, whose work uncovered a crucial role for the tumor suppressor Myc in cellular apoptosis. Here, he talks about the future of cancer therapy and the responsibility of academic science in tackling these complex questions.
CLINICAL PUZZLE
SPECIAL ARTICLE
COMMENTARY
PERSPECTIVE
RESEARCH ARTICLE
RESEARCH REPORT
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
